Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage disease
- 1 January 1991
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 164 (1) , 15-21
- https://doi.org/10.1016/0002-9378(91)90615-x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Epidermal growth factor receptor expression in normal and malignant endometriumAmerican Journal of Obstetrics and Gynecology, 1989
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- Autoradiographic Localization of Epidermal Growth Factor Receptors to All Major Uterine Cell Types1Biology of Reproduction, 1988
- Specific expression of the pS2 gene in subclasses of breast cancers in comparison with expression of the estrogen and progesterone receptors and the oncogene ERBB2.Proceedings of the National Academy of Sciences, 1987
- Stage- and tissue-specific expression of the neu oncogene in rat development.Proceedings of the National Academy of Sciences, 1987
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185Cell, 1986
- The neu oncogene encodes an epidermal growth factor receptor-related proteinNature, 1986
- EPIDERMAL-GROWTH-FACTOR RECEPTORS AND OESTROGEN RECEPTORS IN HUMAN BREAST CANCERThe Lancet, 1985
- Identification of a phosphoprotein specifically induced by the transforming DNA of rat neuroblastomasCell, 1982